C2orf69
Basic information
Region (hg38): 2:199911293-199955935
Links
Phenotypes
GenCC
Source:
- combined oxidative phosphorylation deficiency 53 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Combined oxidative phosphorylation deficiency 53 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Allergy/Immunology/Infectious; Biochemical; Cardiovascular; Gastrointestinal; Neurologic | 33945503; 34038740 |
ClinVar
This is a list of variants' phenotypes submitted to
- Combined oxidative phosphorylation deficiency 53 (1 variants)
- not provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the C2orf69 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 8 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 1 | 1 | 4 | 8 | 0 |
Variants in C2orf69
This is a list of pathogenic ClinVar variants found in the C2orf69 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-199911443-G-T | Inborn genetic diseases | Uncertain significance (Jul 28, 2021) | ||
2-199911455-T-C | Likely benign (Mar 01, 2022) | |||
2-199911521-C-G | Inborn genetic diseases | Uncertain significance (Oct 19, 2022) | ||
2-199911561-G-A | Likely benign (Oct 01, 2023) | |||
2-199911622-G-GGAGCC | Combined oxidative phosphorylation deficiency 53 | Likely pathogenic (Apr 07, 2023) | ||
2-199911642-C-T | Likely benign (Apr 01, 2022) | |||
2-199911684-G-A | Likely benign (Nov 01, 2022) | |||
2-199911716-AG-A | Combined oxidative phosphorylation deficiency 53 | Pathogenic (Jul 09, 2021) | ||
2-199911732-GC-G | Combined oxidative phosphorylation deficiency 53 | Pathogenic (Aug 01, 2021) | ||
2-199911739-C-G | Uncertain significance (Jun 01, 2019) | |||
2-199911747-C-T | C2orf69-related disorder | Likely benign (Aug 09, 2024) | ||
2-199911748-CTCT-C | Combined oxidative phosphorylation deficiency 53 | Pathogenic (Jul 09, 2021) | ||
2-199911758-C-G | Uncertain significance (Jul 05, 2022) | |||
2-199925103-A-G | Likely benign (Nov 01, 2022) | |||
2-199925158-A-T | C2orf69-related disorder | Likely benign (Apr 01, 2022) | ||
2-199925310-TTTTAA-T | Combined oxidative phosphorylation deficiency 53 | Pathogenic (Jul 12, 2021) | ||
2-199925570-AGAAAG-A | Combined oxidative phosphorylation deficiency 53 | Pathogenic (Jul 09, 2021) | ||
2-199925635-CATTCTGGAGGAAGCAAT-C | Combined oxidative phosphorylation deficiency 53 | Pathogenic (Jul 09, 2021) | ||
2-199925657-G-A | Combined oxidative phosphorylation deficiency 53 | Pathogenic (Jul 09, 2021) | ||
2-199925659-G-A | Inborn genetic diseases | Likely benign (Sep 05, 2022) | ||
2-199925738-G-A | Likely benign (Nov 01, 2022) | |||
2-199933071-T-A | not specified | Uncertain significance (Mar 18, 2024) | ||
2-199933094-G-C | not specified | Uncertain significance (Mar 18, 2024) | ||
2-199933116-C-T | not specified | Uncertain significance (Jun 01, 2023) | ||
2-199933119-C-T | not specified | Uncertain significance (Feb 22, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
C2orf69 | protein_coding | protein_coding | ENST00000319974 | 2 | 44680 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0187 | 0.963 | 124595 | 0 | 6 | 124601 | 0.0000241 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.15 | 164 | 211 | 0.778 | 0.0000101 | 2544 |
Missense in Polyphen | 30 | 59.781 | 0.50183 | 792 | ||
Synonymous | 0.217 | 76 | 78.4 | 0.969 | 0.00000368 | 729 |
Loss of Function | 2.07 | 5 | 13.1 | 0.383 | 6.36e-7 | 159 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.0000996 | 0.0000994 |
East Asian | 0.0000556 | 0.0000556 |
Finnish | 0.0000464 | 0.0000464 |
European (Non-Finnish) | 0.0000266 | 0.0000266 |
Middle Eastern | 0.0000556 | 0.0000556 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
Intolerance Scores
- loftool
- 0.144
- rvis_EVS
- 0.39
- rvis_percentile_EVS
- 75.87
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.199
- ghis
- 0.437
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- 1700066M21Rik
- Phenotype
Gene ontology
- Biological process
- Cellular component
- extracellular region
- Molecular function